Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
Early Homebased Rehabilitation for Patients With Severe Heart Failure - An Intersectoral Randomized Controlled Trial
調査の概要
状態
詳細な説明
Approximately 400,000 Danes live today with heart disease. Disease severity is crucial for patients quality of life. Patients with severe heart disease often struggle with everyday life, characterized by reduced physical capacity, tendency to depression and anxiety to perform everyday activities that may provoke symptoms.
A large proportion of patients who are offered cardiac rehabilitation deselect that offer. Of the patients who do participate, more than 50% stop the rehabilitation ahead of time. A large group of patients with severe heart failure and classified in NYHA Class III and IV, deselect the offer because of lack of energy to participate in cardiac rehabilitation or is when specified by a medical assessment discharged from the hospital without the offer of training or any other form of rehabilitation.
The offer of rehabilitation for patients with severe heart failure is lacking as it is today. This study assesses the effectiveness of an early home based rehabilitation program that complements the general psycho-social support, symptom-oriented and preventive medical treatment that these patients always have the option to get.
研究の種類
入学 (予想される)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Laura Staun Valentiner, Master in health scien
- 電話番号:+ 45 39 77 39 51
- メール:laura.risted.staun.valentiner@regionh.dk
研究連絡先のバックアップ
- 名前:Carsten Juhl, Ph.D.stud
- 電話番号:+ 45 39 77 39 51
- メール:carsten.juhl@regionh.dk
研究場所
-
-
Gentofte
-
Copenhagen、Gentofte、デンマーク、2900
- Department of Occupational Therapy and Physiotherapy, Copenhagen University Hospital Gentofte,
-
コンタクト:
- Laura Staun Valentiner, masters in health sciences
- 電話番号:+ 45 39 77 39 51
- メール:laura.risted.staun.valentiner@regionh.dk
-
コンタクト:
- Carsten Juhl, Ph.D stud.
- 電話番号:+ 45 39 77 39 51
- メール:carsten.juhl@regionh.dk
-
主任研究者:
- Laura Staun Valentiner, Masters in Health Science
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Patients admitted to the Gentofte Hospital due to heart failure.
- Patients with a functional equivalent to NYHA grade III or IV
- Patients with ejection fraction <40%
- Patients who score between10-15 in the total score for question 3 dealing with physical functioning in SF-36 questionnaire on health status
- Patients who lives in Gentofte Municipality or Lyngby Tårbæk Municipality.
- Patients who can speak and understand Danish
Exclusion Criteria:
- Patients with cognitive and psychological problems that prevents cooperation (aphasia, dementia, severe depression).
- Patients with terminal illness with expected death within a year.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
実験的:Early homebased rehabilitation
After discharge from the hospital patients are offered a homebased rehabilitation program lasting 6 weeks.
|
Training begins 3-5 days after discharge from hospital, performed by an occupational therapist and a physiotherapist from Gentofte Hospital in the first two weeks.
From week three to six the training will be carried out by an occupational therapist and a physiotherapist from the local municipality (Gentofte municipality and Lyngby Taarbæk municipality).
Training will take place at home twice a week for 6 weeks, each session lasting 45 minutes.
The intervention is individualized and focuses on functional physical and compensatory training to help the patient to manage everyday life at home.
A training program will be provided and the patient will be instructed to do the exercises every day
他の名前:
|
実験的:control group: Ususal care
After discharge from the hospital the patients are offered the usual symptom-oriented and preventive medical care and psychosocial support
|
After discharge from the hospital the patients are offered the usual symptom-oriented and preventive medical care and psychosocial support
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
---|---|
Readmission due to heart failure
時間枠:assessed one year after inclusion
|
assessed one year after inclusion
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Physical capacity
時間枠:Assessed at baseline, after 6 weeks, after 6 month and after one year
|
measured by the Morton Mobility Index, Timed Up & Go and Modified Sit to Stand Test
|
Assessed at baseline, after 6 weeks, after 6 month and after one year
|
Activity of Daily Living
時間枠:Assessed at baseline, after 6 weeks, after 6 month and after one year
|
Recorded at an ADL interview to assess the performance of everyday activities
|
Assessed at baseline, after 6 weeks, after 6 month and after one year
|
Number of total hospital admissions
時間枠:at baseline, after 6 weeks, after 6 month and after one year
|
at baseline, after 6 weeks, after 6 month and after one year
|
|
Exercise Compliance
時間枠:at baseline, after 6 weeks, after 6 month and after one year
|
registration of exercise
|
at baseline, after 6 weeks, after 6 month and after one year
|
Anxiety and depression
時間枠:at baseline, after 6 weeks, after 6 month and after one year
|
measured by Hospital Anxiety and Depression Scale (HAD)
|
at baseline, after 6 weeks, after 6 month and after one year
|
Quality of life
時間枠:at baseline, after 6 weeks, after 6 month and after one year
|
measured by The Minnesota Living with Heart Failure Questionnaire
|
at baseline, after 6 weeks, after 6 month and after one year
|
Number of patients who starts outpatient cardiac rehabilitation after intervention (municipality or hospital)
時間枠:at 6 weeks, after 6 month and after one year
|
at 6 weeks, after 6 month and after one year
|
協力者と研究者
研究記録日
主要日程の研究
研究開始
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- H-2-2012-021
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
慢性心不全の臨床試験
-
Novartis Pharmaceuticals完了EC-MPS による治療に関心があり、コア研究の 12 か月の治療期間を無事に完了した患者 (de novo Heart Recipients)